CANDONI , Anna

Last name: CANDONI

First name: Anna

2020 (v1)

Publication

Metadata-only

CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian compassionate use program

Guolo, Fabio Fianchi, Luana Minetto, Paola

Secondary acute myeloid leukemia (sAML) poorly responds to conventional treatments and allogeneic stem cell transplantation (HSCT). We evaluated toxicity and efficacy of CPX-351 in 71 elderly patients (median age 66 years) with sAML enrolled in the Italian Named (Compassionate) Use Program. Sixty days treatment-related mortality was 7% (5/71)....

Uploaded on: April 14, 2023
2024 (v1)

Publication

Metadata-only

Antiviral prophylaxis to prevent herpes simplex virus (HSV) and varicella zoster virus (VZV) reactivation in adult patients with newly diagnosed acute leukemia: results of a survey submitted to Italian centers belonging to SEIFEM (Sorveglianza Epidemiologica Infezioni nelle Emopatie) group

Forghieri, Fabio Cordella, Stefano Marchesi, Francesco

No description

Uploaded on: October 26, 2024
2023 (v1)

Publication

Metadata-only

Multicenter Observational Retrospective Study on Febrile Events in Patients with Acute Myeloid Leukemia Treated with Cpx-351 in "Real-Life": The SEIFEM Experience

Fianchi, Luana Guolo, Fabio Marchesi, Francesco

Simple Summary CPX-351 has been approved for the treatment of adults with therapy-related AML (t-AML) or AML with myelodysplasia-related changes (AML-MRC). The aim of this retrospective study was to evaluate the absolute infectious risk in a real-life setting of 200 AML patients treated with this drug. A total of 249 febrile events were...

Uploaded on: October 25, 2024
2022 (v1)

Publication

Metadata-only

INCB84344-201: Ponatinib and steroids in frontline therapy for unfit patients with Ph+ acute lymphoblastic leukemia

Martinelli, Giovanni Papayannidis, Cristina Piciocchi, Alfonso

Tyrosine kinase inhibitors have improved survival for patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL). However, prognosis for old or unfit patients remains poor. In the INCB84344-201 (formerly GIMEMA LAL 1811) prospective, multicenter, phase 2 trial, we tested the efficacy and safety of ponatinib plus...

Uploaded on: March 27, 2023

CANDONI , Anna

Recent uploads